CORETOX Trademark

Trademark Overview

On Thursday, December 31, 2015, a trademark application was filed for CORETOX with the United States Patent and Trademark Office. The USPTO has given the CORETOX trademark a serial number of 79195273. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 15, 2023. This trademark is owned by Medytox Inc.. The CORETOX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations for the treatment of cerebral palsy, headaches, migraines, ophthalmological disorders, hyperhidrosis, acne; muscle relaxants; therapeutic drugs and agents for the treatment of orthopaedic disorders, namely, hip dislocation, spinal column deformation, curvature of the spine, namely, scoliosis, lordosis, kyphosis; pharmaceutical preparations for treating the peripheral nervous system; bacterial poisons; pharmacological preparations for skin care; pharmaceutical agents for treating the epidermis; injectable dermal filler; pharmaceutical preparations for treating the central nervous system; Pharmaceutical preparations for the treatment of muscle fatigue; vaccines
coretox

General Information

Serial Number79195273
Word MarkCORETOX
Filing DateThursday, December 31, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 15, 2023
Registration Number5211407
Registration DateTuesday, May 30, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2017

Trademark Statements

Goods and ServicesPharmaceutical and veterinary preparations for the treatment of cerebral palsy, headaches, migraines, ophthalmological disorders, hyperhidrosis, acne; muscle relaxants; therapeutic drugs and agents for the treatment of orthopaedic disorders, namely, hip dislocation, spinal column deformation, curvature of the spine, namely, scoliosis, lordosis, kyphosis; pharmaceutical preparations for treating the peripheral nervous system; bacterial poisons; pharmacological preparations for skin care; pharmaceutical agents for treating the epidermis; injectable dermal filler; pharmaceutical preparations for treating the central nervous system; Pharmaceutical preparations for the treatment of muscle fatigue; vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMedytox Inc.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressChungcheongbuk-do
KR
Party NameMedytox Inc.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressChungcheongbuk-do
KR
Party NameMedytox Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressChungcheongbuk-do
KR

Trademark Events

Event DateEvent Description
Tuesday, November 8, 2016APPLICATION FILING RECEIPT MAILED
Monday, November 28, 2016NON-FINAL ACTION WRITTEN
Thursday, November 3, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, November 4, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 4, 2016ASSIGNED TO EXAMINER
Monday, November 7, 2016NON-FINAL ACTION WRITTEN
Tuesday, November 8, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, November 17, 2016NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Saturday, February 4, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 29, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, November 29, 2016REFUSAL PROCESSED BY MPU
Wednesday, November 30, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, December 17, 2016REFUSAL PROCESSED BY IB
Monday, January 9, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 27, 2017ASSIGNED TO LIE
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 31, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 1, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 22, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, March 14, 2017PUBLISHED FOR OPPOSITION
Friday, September 8, 2017FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, February 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 22, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, March 10, 2017NOTIFICATION PROCESSED BY IB
Tuesday, March 14, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, August 30, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, September 8, 2017FINAL DISPOSITION PROCESSED
Friday, August 16, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, September 9, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, September 9, 2024INVALIDATION PROCESSED
Saturday, October 28, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, May 30, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, December 15, 2023CANCELLED SECTION 71
Monday, September 30, 2024TOTAL INVALIDATION PROCESSED BY THE IB

Related Keywords

coretox preparations pharmaceutical treating treatment namely agents nervous disorders system muscle